PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Demand for New Technology Underlines the Growing Appeal of Immunochemistry Analysers - New analysis from Frost & Sullivan, European Immunochemistry Analysers Market, estimates that the market will be worth $164.7 million in 2007 and will reach $412.4 million by 2012
Demand for New Technology Underlines the Growing Appeal of Immunochemistry Analysers

 

NewswireToday - /newswire/ - London, United Kingdom, 2008/02/04 - New analysis from Frost & Sullivan, European Immunochemistry Analysers Market, estimates that the market will be worth $164.7 million in 2007 and will reach $412.4 million by 2012.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Immunochemistry analysers are only now beginning to replace clinical chemistry and immunoassay analysers. Manufacturers are developing several alternatives for laboratories with varying workloads, personnel and budgets. Test menu and configuration offerings differ from manufacturer to manufacturer and new or improved assays are being added to test menus incrementally.

New analysis from Frost & Sullivan (drugdiscoverytechnologies.frost.com), European Immunochemistry Analysers Market, estimates that the market will be worth $164.7 million in 2007 and will reach $412.4 million by 2012.

"Even while the majority of the segments in the clinical laboratory analyser market, including clinical chemistry, haematology and urinalysis, are mature and have limited capacity for further growth, the newly developed segments of integrated analysers such as immunochemistry are experiencing high growth and contributing to overall market expansion," notes Frost & Sullivan Programme Manager Dr. Fiona Rahman. "Segments such as immunochemistry are experiencing steady demand due to an increase in test menus, particularly in cardiac and tumour assays."

With the recent introduction of integrated analysers that combine chemistry and immunoassay on one platform, the number of chemistry analysers purchased is projected to decline gradually. Immunochemistry analysers have the advantage of offering two analysers on one platform, resulting in their rapid adoption by laboratories.

Feedback has shown that laboratories are investing in immunochemistry analysers as they provide a growing range of tests for thyroid function, cardiac and cancer markers, fertility/reproductive markers, infectious disease and retroviral markers, metabolic markers and therapeutic drug monitoring. Immunochemistry systems analyse blood, saliva and urine and utilise several methodologies including enzyme immunoassay (EIA), coated microplate, chemiluminescence and fluorescence.

However, clinical laboratories are often hesitant to switch to a different brand of analysers due to the costs associated with the transition, which can involve retraining staff, restandardising practices and updating data management systems. Occasionally, even when laboratory managers and personnel are dissatisfied with their current instrument or service, they baulk at purchasing another manufacturer's product because the decision process and implementation can take a long time.

"Due to laboratory consolidation, the immunochemistry analyser market relies heavily on system replacements in order to generate revenue; manufactures have had to generate sales by replacing old clinical chemistry or immunoassay systems with integrated analysers or have had to win clients from other vendors," explains Dr. Rahman. "As competition becomes aggressive, analyser vendors continue to experience difficulties in increasing their customer base and demonstrating the benefits of immunochemistry analysers."

To further exacerbate the effects of this challenge, many laboratories resist buying new, expensive, high-technology immunochemistry analysers and are urgently attempting to achieve maximum returns on their investments.

"In light of increasing revenues from immunochemistry analyser sales, manufacturers should promote pre and post sample management and integration options to boost revenue streams from instrumentation sales," advises Dr. Rahman. "Additionally, customers should be encouraged to upgrade to integrated immunochemistry systems to increase productivity and reduce labour costs in the long term."

Enhanced levels of automation will also result in customers being tied down to a single vendor, while allowing vendors to successfully generate more long-term revenues from a single customer site.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the investment analysis and growth opportunities in the European immunochemistry analysers market, then send an email to Patrick Cairns, Corporate Communications, at patrick.cairns[.]frost.com, with your full name, company name, title, telephone number, fax number, and email address. Upon receipt of the above information, an overview will be sent to you by email.

European Immunochemistry Analysers Market is part of the Drug Discovery & Clinical Diagnostics Growth Partnership Service programme, which also includes research in the following markets: European Coagulation Diagnostics Markets, European IVD Market and European Haematology Diagnostic Market and European Clinical Diagnostics Automation Markets. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

About Frost & Sullivan
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Demand for New Technology Underlines the Growing Appeal of Immunochemistry Analysers

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Patrick Cairns 
+27 83 258 4219 patrick.cairns[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)